SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001171843-18-006363
Filing Date
2018-09-04
Accepted
2018-09-04 13:00:47
Documents
2
Period of Report
2018-09-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A f8ka_090418.htm 8-K/A 13921
2 PRESS RELEASE exh_991.htm EX-99.1 25442
  Complete submission text file 0001171843-18-006363.txt   40495
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-23186 | Film No.: 181051815
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1